Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
20
AFCG Quote, Financials, Valuation and Earnings
Last price:
$2.88
Seasonality move
:
-14.55%
Day range:
$2.81 - $2.92
52-week range:
$2.52 - $8.88
Dividend yield:
30.18%
P/E ratio:
4.43x
P/S ratio:
1.85x
P/B ratio:
0.38x
Volume:
232.7K
Avg. volume:
286.7K
1-year change:
-65.79%
Market cap:
$64.4M
Revenue:
$51.9M
EPS (TTM):
-$1.04
Analysts' Opinion
-
Consensus RatingAdvanced Flower Capital, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.50, Advanced Flower Capital, Inc. has an estimated upside of 128.07% from its current price of $2.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $2.85.
Fair Value
-
According to the consensus of 3 analysts, Advanced Flower Capital, Inc. has 128.07% upside to fair value with a price target of $6.50 per share.
AFCG vs. S&P 500
-
Over the past 5 trading days, Advanced Flower Capital, Inc. has overperformed the S&P 500 by 3.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Advanced Flower Capital, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Advanced Flower Capital, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Advanced Flower Capital, Inc. reported revenues of $8.2M.
Earnings Growth
-
Advanced Flower Capital, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Advanced Flower Capital, Inc. reported earnings per share of -$0.57.
Enterprise value:
130.3M
EV / Invested capital:
--
Price / LTM sales:
1.85x
EV / EBIT:
11.17x
EV / Revenue:
3.84x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
9.30x
Price / Operating cash flow:
4.48x
Enterprise value / EBITDA:
11.17x
Gross Profit (TTM):
$29.8M
Return On Assets:
-6.76%
Net Income Margin (TTM):
-66.59%
Return On Equity:
-11.73%
Return On Invested Capital:
-6.97%
Operating Margin:
-136.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $73.2M | $59.9M | $33.9M | $10.5M | $8.2M | |
| Gross Profit | $58.7M | $48M | $29.8M | $9.5M | $7.4M | |
| Operating Income | $39.3M | $13.3M | -$16.2M | $3.2M | -$11.2M | |
| EBITDA | $47.6M | $24.1M | $11.7M | $3.4M | -$3.8M | |
| Diluted EPS | $1.61 | $0.34 | -$1.04 | $0.06 | -$0.57 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $72.4M | $40.8M | $77.8M | $123.6M | $45.9M | |
| Total Assets | $303.9M | $471.3M | $445.1M | $366.6M | $288.7M | |
| Current Liabilities | $28.8M | $26.3M | $18.3M | $11.9M | $8.2M | |
| Total Liabilities | $29.5M | $123.9M | $106.3M | $160.6M | $119.4M | |
| Total Equity | $274.4M | $347.4M | $338.8M | $206.1M | $169.3M | |
| Total Debt | -- | $97M | $87.9M | $148.5M | $111.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $18.9M | $25.6M | $14M | $2.6M | $6.1M | |
| Cash From Investing | $70.7M | $62.1M | -$33.1M | -$7M | $27.4M | |
| Cash From Financing | -$52.7M | -$38.7M | -$58M | -$43.8M | $8.2M | |
| Free Cash Flow | $18.9M | $25.6M | $14M | $2.6M | $6.1M | |
AFCG
Sector
Market Cap
$64.4M
$554M
Price % of 52-Week High
32.1%
90.96%
Dividend Yield
30.18%
1.58%
Shareholder Yield
21.06%
3.08%
1-Year Price Total Return
-65.79%
6.77%
Beta (5-Year)
--
0.463
Dividend yield:
30.18%
Annualized payout:
$1.41
Payout ratio:
369.85%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$2.92
200-day SMA
Sell
Level
$4.36
Bollinger Bands (100)
Sell
Level
2.96 - 4.28
Chaikin Money Flow
Sell
Level
-21M
20-day SMA
Sell
Level
$3.00
Relative Strength Index (RSI14)
Sell
Level
44.88
ADX Line
Sell
Level
16.19
Williams %R
Buy
Level
-83.3231
50-day SMA
Sell
Level
$3.06
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Sell
Level
-19M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9919)
Buy
CA Score
(Annual)
Level (0.299)
Buy
Beneish M-Score
(Annual)
Level (-3.9038)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.7551)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Advanced Flower Capital, Inc. provides commercial real estate finance services. It primarily engages in originating, structuring, underwriting and managing senior secured loans and other types of loans for established companies operating in the cannabis industry in states. The company was founded by Leonard Mark Tannenbaum on July 6, 2020 and is headquartered in West Palm Beach, FL.
Stock Forecast FAQ
In the current month, AFCG has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The AFCG average analyst price target in the past 3 months is $6.50.
-
Where Will Advanced Flower Capital, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Advanced Flower Capital, Inc. share price will rise to $6.50 per share over the next 12 months.
-
What Do Analysts Say About Advanced Flower Capital, Inc.?
Analysts are divided on their view about Advanced Flower Capital, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Advanced Flower Capital, Inc. is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Advanced Flower Capital, Inc.'s Price Target?
The price target for Advanced Flower Capital, Inc. over the next 1-year time period is forecast to be $6.50 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is AFCG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Advanced Flower Capital, Inc. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AFCG?
You can purchase shares of Advanced Flower Capital, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Advanced Flower Capital, Inc. shares.
-
What Is The Advanced Flower Capital, Inc. Share Price Today?
Advanced Flower Capital, Inc. was last trading at $2.88 per share. This represents the most recent stock quote for Advanced Flower Capital, Inc.. Yesterday, Advanced Flower Capital, Inc. closed at $2.85 per share.
-
How To Buy Advanced Flower Capital, Inc. Stock Online?
In order to purchase Advanced Flower Capital, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AFCG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AFCG
Sector
P/E ratio
4.43x
12.15x
PEG ratio
0.05x
0.31x
P/B ratio
0.38x
1.10x
Price / LTM sales
1.85x
1.82x
Growth Metrics
AFCG
Sector
Revenue growth
-21.93%
5.54%
Earnings growth
-1071.11%
14.85%
Revenue (5-year growth)
--
8.84%
Earnings forecast
-$0.07
$0.64
Profitability
AFCG
Sector
Profitability FY 2024
$41.5M
--
Return on invested capital
-6.97%
5.01%
Return on assets
-6.76%
1.01%
Return on equity
-11.73%
9.67%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
11
Balance Sheet
AFCG
Sector
Total cash
$45.1M
$430.8M
Short term investments
--
$211.1M
Total assets
$402.1M
$3.1B
Long term debt
$111.1M
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.09% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.81% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.27% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
